Stock 002365 QIANJIANG YONGAN PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Qianjiang Yongan Pharmaceutical Co., Ltd.

Equities

002365

CNE100000LZ9

End-of-day quote Shenzhen S.E.
Other stock markets
 18:00:00 2024-06-02 EDT 		5-day change 1st Jan Change
7.55 CNY -3.45% Intraday chart for Qianjiang Yongan Pharmaceutical Co., Ltd. -3.82% -22.80%
04-29 Qianjiang Yongan Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 80 million worth of its shares. CI
04-29 Qianjiang Yongan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Qianjiang Yongan Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 80 million worth of its shares.
CI
Qianjiang Yongan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Qianjiang Yongan Pharmaceutical Co., Ltd. authorizes a Buyback Plan.
CI
Qianjiang Yongan Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Qianjiang Yongan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Qianjiang Yongan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Qianjiang Yongan Pharmaceutical Co., Ltd Approves Cash Dividend for the Year 2022, Payable on July 5, 2023
CI
Yongan Pharma Registers New Health Food Products
MT
Qianjiang Yongan Pharma to Buy 6.5% Stake in Local Chemical Producer For 30 Million Yuan
MT
Qianjiang Yongan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Qianjiang Yongan Pharmaceutical Co., Ltd. Proposes Final Dividend for the Year 2022
CI
Qianjiang Yongan Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Qianjiang Yongan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Qianjiang Yongan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Qianjiang Yongan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Qianjiang Yongan Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Qianjiang Yongan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
CI
Qianjiang Yongan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
CI
Qianjiang Yongan Pharmaceutical Co., Ltd. Announces Final Cash Dividend for 2020, Payable on July 9, 2021
CI
Yongan Pharmaceutical Approves Final Cash Dividend for the Year 2020
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 002365 Stock
  4. News Qianjiang Yongan Pharmaceutical Co., Ltd.
  5. Highlights